This article is written like an advertisement. Please help rewrite this article from a neutral point of view. For blatant advertising that would require a major rewrite to become encyclopedic, use {{QD|spam}} to mark for quick deletion. (September 2024)

This subject may not be notable enough for an article according to our general notability guideline. Please help by adding reliable sources about the subject and saying why it is notable. Otherwise, it can be merged, redirected, or deleted from Wikipedia. (October 2024)

Prof. Dr. Stefan Bittmann, M.A. is a renowned pediatrician and Professor of Pediatrics at the School of Medicine, Shangluo Vocational and Technical College, University in China. He is also affiliated with the Medical and Financial Center Gronau in Germany. Prof. Bittmann is known for his significant contributions to pediatrics and his role as an international medical consultant. He has actively promoted medical science and cooperation between China and Germany and made notable contributions to global health initiatives and research, especially in the field of pediatrics.^{[1] [2] [3]}

Stefan Bittmann was born on September 26, 1968 in Münster (Westphalia). He studied medicine at the Ludwig Maximilian University in Munich, where he developed a great interest in pediatrics. He continued his education with specializations and research in the field of pediatric diseases, focusing on rare genetic diseases and therapeutic innovations.

^{[4] [5] [6] [7]}

Bittmann’s research covers a wide range of pediatric diseases and innovative treatments. His notable publications include: “Childhood Allan-Herndon-Dudley Syndrome: Is There No Cure?” Asian Journal of Pediatric Research, Volume 14, Issue 7, 2024. “Selective Allosteric Phosphodiesterase 4D (PDE4D) Inhibitors for the Treatment of FMR-1 Gene Defects and Other Pediatric Syndrome Disorders Associated with Cognitive Impairment” Asian Journal of Pediatric Research, Volume 14, Issue 7, 2024. “Research on Liver Organoids: Current Situation, Limiting Factors and Future Therapeutic Potential in Pediatric Diseases” in Advancement and New Understanding in Medical Science, Volume. 10. “Primary bile acid disorders: A largely unknown group of rare genetic disorders in newborns,” Asian Journal of Pediatric Research, Volume 14, Issue 5, 2024. “The role of fibroblast growth factor receptor signaling pathway aberrations in pediatric diseases,” Asian Journal of Pediatric Research, Volume 14, Issue 4, 2024. Bittmann has also contributed to several book chapters and research monographs on pediatric liver diseases and the genetic architecture of rare diseases.

Bittmann has played a crucial role in promoting international medical cooperation. He helped coordinate the Belt and Road Central Asia Medical and Pediatric Alliance, which promotes medical science and cooperation between China and Germany. He supported and participated in the compilation of the book “International Research on Kawasaki Disease”, made contributions to clinical research, and received the Science and Technology Progress Award of Shaanxi Province in 2019. He organized and participated in several international medical conferences, including the Eurasian Pediatric Summit (2019) and various online seminars on epidemic prevention and COVID-19.

Bittmann is an advocate of pediatric telemedicine, researching its potential in diagnosing and treating pediatric abdominal pain and other conditions. He has published articles on the advances in pediatric telemedicine and its application in various clinical settings.

Bittmann is actively involved in promoting Traditional Chinese Medicine (TCM) through the European Center for Traditional Chinese Medicine. He has been instrumental in bridging Western and Chinese medical practices and advocating for the integration of TCM methods and education in international medical communities.

Bittmann's contributions to medical research and international collaboration have been recognized with several awards, including the Shaanxi Province Science and Technology Progress Award. His work has significantly advanced the understanding and treatment of childhood diseases, particularly rare genetic disorders.